Evidence map›Paper›PMID 35038025›Full record

ReviewAmino acids2022

Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function.

Niall P Hyland, Cassandre R Cavanaugh, Pamela J Hornby

Abstract readReview
PubMed Publisher
In one paragraph

Review in Amino acids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Proteases in intestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Intestinal-related substances in obesity regulation: A comprehensive review.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Niall P HylandDepartment of Physiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.ORCID http://orcid.org/0000-0003-0060-7390
Cassandre R Cavanaugh *Cardiovascular and Metabolic Disease Discovery, Janssen R&D, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.ORCID https://orcid.org/0000-0002-5446-2871
Pamela J Hornby *Cardiovascular and Metabolic Disease Discovery, Janssen R&D, LLC, 1400 McKean Road, Spring House, PA, 19477, USA. phornby@its.jnj.com.ORCID http://orcid.org/0000-0002-8606-8297
Springhouse · USUniversity College Cork · IE

Funding

Science Foundation Ireland 15/IFB/3578
6 · The paper itself

Abstract

The metabolism of dietary tryptophan occurs locally in the gut primarily via host enzymes, with ~ 5% metabolized by gut microbes. Three major tryptophan metabolic pathways are serotonin (beyond the scope of this review), indole, kynurenine and related derivatives. We introduce the gut microbiome, dietary tryptophan and the potential interplay of host and bacterial enzymes in tryptophan metabolism. Examples of bacterial transformation to indole and its derivative indole-3 propionic acid demonstrate associations with human metabolic disease and gut permeability, although causality remains to be determined. This review will focus on less well-known data, suggestive of local generation and functional significance in the gut, where kynurenine is converted to kynurenic acid and xanthurenic acid via enzymatic action present in both host and bacteria. Our functional data demonstrate a limited effect on intestinal epithelial cell monolayer permeability and on healthy mouse ileum. Other data suggest a modulatory effect on the microbiome, potentially in pathophysiology. Supportive of this, we found that the expression of mRNA for three kynurenine pathway enzymes were increased in colon from high-fat-fed mice, suggesting that this host pathway is perturbed in metabolic disease. These data, along with that from bacterial genomic analysis and germ-free mice, confirms expression and functional machinery of enzymes in this pathway. Therefore, the host and microbiota may play a significant dual role in either the production or regulation of these kynurenine metabolites which, in turn, can influence both host and microbiome, especially in the context of obesity and intestinal permeability.

Indexed as

Gastrointestinal MicrobiomeAnimalsIntestinesKynurenineMiceObesityTryptophanKynurenineTryptophanColonIndoleIntestinal permeabilityKynurenineMetabolic endotoxemiaMicrobiomeObesityType 2 diabetes

Identifiers

PMID35038025
OpenAlexW4206164796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.